Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

96.69
-2.1400-2.17%
Pre-market: 97.921.23+1.27%05:06 EDT
Volume:8.86M
Turnover:862.35M
Market Cap:168.13B
PE:31.29
High:99.45
Open:99.10
Low:96.54
Close:98.83
52wk High:135.37
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:1.22
T/O Rate:0.52%
Dividend:2.48
Dividend Rate:2.56%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.29
PE(LYR):25.92

Loading ...

Texas Governor Abbott directs comprehensive data center audit

TIPRANKS
·
Aug 04

Movement Alert|Abbott Laboratories Rises 3.21% in Regular Trading, FDA Approval of Colorectal Cancer Blood Screening Test Continues to Boost Shares

Market Focus
·
Aug 03

Perrigo Co. PLC Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Abitare In closes €141 million project sale and seeks exit from STAR segment

TIPRANKS
·
Jul 31

Abbott Laboratories Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 31

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Power Your Cash Flow, 7/30/26

TIPRANKS
·
Jul 31

Movement Alert|Abbott Laboratories Falls 3.08% in Regular Trading, Multiple Banks Cut Target Prices Triggering Pullback Pressure

Market Focus
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Labs is Maintained at Buy by UBS

Dow Jones
·
Jul 29

Movement Alert|Abbott Laboratories Rises 3.07% in Regular Trading, FDA Approves Its Exclusive Colorectal Cancer Blood Screening Test

Market Focus
·
Jul 28

Abbott price target lowered to $125 from $135 at UBS

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Abitare In Publishes 2025 Sustainability Report, Underscoring Urban Regeneration Strategy

TIPRANKS
·
Jul 28

Leah Bennett: Where to Invest After the AI-Chip Stock Surge

Dow Jones
·
Jul 27

Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment

MT Newswires Live
·
Jul 27

US Companies Face Rise in Cyber Attacks

Reuters
·
Jul 27

FDA Approves Freenome’S Simplescreen™ Crc Blood-Based Screening Test Abbott to Commercialize in the U.S.

Reuters
·
Jul 27

Freenome, Abbott announce FDA approval of SimpleScreen CRC

TIPRANKS
·
Jul 27